Remove 2010 Remove Communication Remove Hospitals
article thumbnail

Partnering With Microbiology Laboratory To Bring Awareness To Antimicrobial Resistance

IDStewardship

Antimicrobial Resistance Champions As a part of the #ASPchat discussion, participants shared creative ideas to help broaden the ripple effect of communications to better inform the world about the threat of AMR. Following this, he completed a PGY2 infectious diseases pharmacy specialty residency at Houston Methodist Hospital, Houston, TX.

Hospitals 223
article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 340B providers expressed significant concern.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

9 home remedies for sinus infections

The Checkup by Singlecare

This is a common medical condition: Sinus infections affect about 35 million Americans annually and are responsible for almost 16 million hospital visits each year. Luke’s Hospital (2005) The post 9 home remedies for sinus infections appeared first on The Checkup.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

As per the US Department of Justice release, Novartis Greece admitted making improper payments to Greek healthcare providers between 2009 and 2010, for an epidemiological study that was intended to increase sales of Novartis prescription drugs. Please check your email to download the Report.

article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

Citing studies comparing such products, there are no important differences between biosimilars and their branded counterpart, says Arnold Vulto, PharmD, professor of hospital pharmacy at Erasmus University, Rotterdam. These biosimilars are likely interchangeable even without a designation, he says.

article thumbnail

Patient insights into the decentralisation of clinical trials

European Pharmaceutical Review

Technological advances in electronic communication and health data monitoring allow for fewer in-person visits in both clinical trials and care. Another element is home assessments – removing the need for patients to come into the physician’s office or hospital each time. One area of innovation is clinical trial decentralisation.

article thumbnail

How common are changes to the primary endpoint in oncology RCTs?

Hospital Pharmacy Europe

Nevertheless, it is incumbent on trialists to communicate such changes. appeared first on Hospital Pharmacy Europe. It is also possible that, as the trial continues, emerging evidence from other studies may suggest a more appropriate endpoint. Based on the current evidence, this does not appear to be a common practice.